Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8309607 | Clinica Chimica Acta | 2018 | 6 Pages |
Abstract
An increase in serum tenascin-C level is associated with an adverse outcome in ICH patients, supporting the potential role of serum tenascin-C as a prognostic biomarker for hemorrhagic stroke.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Lin-Guo Wang, Xue-Qin Huangfu, Bo Tao, Guan-Jin Zhong, Zhou-Di Le,